pharma companies are no longer just investing in digital health
they are operationalizing tech across the enterprise
Don't miss this highly anticipated, invitation-only lunch event that will allow you to gain an understanding of how pharma is embracing tech-driven innovation. Join us to hear from some of the leading industry experts and change-makers - while also networking and taking part in the discussion.
You were carefully selected to attend this premier event, so we kindly ask that you do not transfer your ticket without prior approval.
RSVP Deadline: December 18th
Tina has more than 18 years of pharmaceutical industry experience in a variety of roles within Finance, Strategy & Operations, and Market Access. Currently, she is the Executive Director, Market Access Marketing & Innovation for Boehringer Ingelheim Pharmaceuticals. In this role, Tina leads three distinct teams ; Access Solutions which is responsible for driving strategies for all Patient Access and Affordability programs, Strategic Customer Collaborations which is responsible for Transforming development and commercialization through effective customer collaboration and Digital Health which is responsible for redefining the products we offer customers with Digital Health offerings. All of these functions contribute to the ultimate goal of improving patient outcomes.
Anurati is the Founder and CEO of Sempre Health - the first company to align the interests of pharmaceutical companies, health insurers and patients to boost the country’s medication adherence rate. Addressing the pressing national issue of high drug costs, Sempre Health redistributes dollars earmarked by pharma companies for patient assistance to health plans, who offer discounts to patients in the form of lower copays as they exhibit healthy behaviors, such as refilling medications on time. Reminiscent of “good driver discounts” offered by auto Insurance companies, Sempre’s dynamic discount program rewards health plan members for adhering to medication therapies. The company works with leading payors like BlueCrossBlueShield Arizona and UPMC, as well as many of the country’s top pharmaceutical companies.
Arif Nathoo, M.D., is co-founder & chief executive officer at Komodo Health where he oversees data sciences, engineering, and product development initiatives for the company. He has spent the past 15 years in healthcare and life sciences leadership roles. Before Komodo Health, Arif was a leader in McKinsey’s Healthcare practice where he was responsible for helping enterprise healthcare address issues in corporate strategy, finance, sales and marketing, and organization building. He co-led McKinsey’s Medical Affairs Practice, which created analytic products and services to improve non-promotional engagement between industry and providers.
Jen Goldsack leads Strategy, Portfolio and Operations at HealthMode and serves as the Interim Executive Director of the Digital Medicine Society (DiMe). Previously, Jen spent several years at the Clinical Trials Transformation Initiative (CTTI) where she led development and implementation several projects within CTTI’s Mobile Program and was the operational co-lead on the first randomized clinical trial using FDA’s Sentinel System. Jen spent five years working in research at the Hospital of the University of Pennsylvania, first in Outcomes Research in the Department of Surgery and later in the Department of Medicine. More recently, she helped launch the Value Institute, a pragmatic research and innovation center embedded in a large academic medical center in Delaware. Jen earned her master’s degree in chemistry from the University of Oxford, England, her masters in the history and sociology of medicine from the University of Pennsylvania, and her MBA from the George Washington University. Additionally, she is a certified Lean Six Sigma Green Belt and a Certified Professional in Healthcare Quality. Ms Goldsack is a retired athlete, formerly a Pan American Games Champion, Olympian and World Championship silver medalist.
Rebecca Robbins is a reporter for STAT covering health tech and life sciences in the Bay Area. She co-authors the weekly newsletter STAT Health Tech and co-hosts the weekly biotech podcast The Readout LOUD. She previously reported for the Washington Post, the Hartford Courant, and the Santa Barbara Independent. Rebecca earned a history degree at Harvard University, where she spent a year as managing editor of the Harvard Crimson.
